Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Lena Thiman"'
Autor:
Mariam Bagher, Leif Bjermer, Gunilla Westergren-Thorsson, Claes-Göran Löfdahl, Lena Thiman, Anna-Karin Larsson-Callerfelt, Annika Andersson-Sjöland, Oskar Hallgren
Publikováno v:
Respirology. 23:68-75
Background and objective Involvement of pulmonary vascular remodelling is a characteristic sign in COPD. Vascular mediators such as vascular endothelial growth factor (VEGF) and prostacyclin may regulate fibroblast activity. The objective was to stud
Autor:
Lena Thiman, Hillevi Larsson, Gunilla Westergren-Thorsson, Leif Bjermer, Anna-Karin Larsson-Callerfelt, Oskar Hallgren, Catharina Müller, Leif Eriksson, Annika Andersson-Sjöland
Publikováno v:
Respiratory medicine. 166
Chronic lung allograft dysfunction including Bronchiolitis obliterans syndrome (BOS) is common after lung transplantation. Histologically, BOS is recognized as fibrotic lesions with accumulated extracellular matrix (ECM) in small airways. Lung fibrob
Autor:
Mariam Bagher, Claes-Göran Löfdahl, Anna-Karin Larsson-Callerfelt, Gunilla Westergren-Thorsson, Oskar Hallgren, Lena Thiman, Leif Bjermer, Annika Andersson Sjöland
Publikováno v:
Airway Pharmacology and Treatment.
Pulmonary vascular remodelling is a characteristic sign in different lung disorders. Vascular endothelial growth factor (VEGF) is a key mediator in vascular remodelling. The objective was to study the role of VEGF on fibroblast activity, such as extr
Autor:
Gunilla, Westergren-Thorsson, Mariam, Bagher, Annika, Andersson-Sjöland, Lena, Thiman, Claes-Göran, Löfdahl, Oskar, Hallgren, Leif, Bjermer, Anna-Karin, Larsson-Callerfelt
Publikováno v:
Respirology (Carlton, Vic.). 23(1)
Involvement of pulmonary vascular remodelling is a characteristic sign in COPD. Vascular mediators such as vascular endothelial growth factor (VEGF) and prostacyclin may regulate fibroblast activity. The objective was to study the synthesis of VEGF a
Autor:
Anna-Karin Larsson-Callerfelt, Gunilla Westergren-Thorsson, Leif Bjermer, Oskar Hallgren, Claes-Göran Löfdahl, Annika Andersson-Sjöland, Lena Thiman
Publikováno v:
QJM: An International Journal of Medicine.
Autor:
Hanna L. Karlsson, Lena Thiman, Gunilla Westergren-Thorsson, Anna-Karin Larsson-Callerfelt, Vendela Rissler
Publikováno v:
5.1 Airway Pharmacology and Treatment.
Background: Nanoparticles (1-100 nm) possess unusual properties related to size, shape, and chemical composition and can be used for specific targeting of cells and potential drug delivery. However, the use of nanoparticles for drug delivery into the
Autor:
Lennart Hansson, Leif Bjermer, Annika Andersson Sjöland, Oskar Hallgren, Lena Thiman, Anna-Karin Larsson Callerfelt, Leif Eriksson, Gunilla Westergren-Thorsson, Ingrid Skog
Publikováno v:
3.3 Mechanisms of Lung Injury and Repair.
Many lung-transplanted (LTx) patients develop obliterative bronchiolitis (OB) with deposition of extracellular matrix, accompanied by fibrocyte infiltration and increased lumen of vessels. In this study we hypothesize that fibrocytes, VEGF and prosta
Autor:
Anna Löfdahl, Catharina Müller, C. Martina Holst, Anna-Karin Larsson-Callerfelt, Gunilla Westergren-Thorsson, Gunilla Ekstrom, Kristina Rydell-Törmänen, Christina Wenglén, Lena Thiman
Publikováno v:
Physiological Reports
Pulmonary fibrosis is characterized by excessive accumulation of connective tissue, along with activated extracellular matrix (ECM)‐producing cells, myofibroblasts. The pathological mechanisms are not well known, however serotonin (5‐HT) and 5‐
Publikováno v:
Experimental Cell Research. 308:254-264
Polyamines are organic cations, which are considered essential for normal cell cycle progression. This view is based on results from numerous studies using a variety of enzyme inhibitors or polyamine analogues interfering with either the metabolism o
Autor:
Ingrid Skog, Sara Rolandsson, Lena Thiman, Gunilla Westergren-Thorsson, Oskar Hallgren, Lennart Hansson, Lena Mared, Leif Eriksson, Kristian Nihlberg, Leif Bjermer, Annika Andersson Sjöland
Publikováno v:
C92. INSIGHTS INTO THE PATHOGENESIS OF LUNG ALLOGRAFT DYSFUNCTION.